Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx Import Debate Launches In Senate With Introduction Of Four Bills

Executive Summary

The drug importation debate was launched in the Senate the week of Jan. 24 with the introduction of several bills

You may also be interested in...



European Drug Importation Shows Few Safety Risks, Small Savings – AARP

The European experience with commercial drug importation indicates the practice poses few safety risks but provides little in savings for patients, an AARP report released June 22 concludes

European Drug Importation Shows Few Safety Risks, Small Savings – AARP

The European experience with commercial drug importation indicates the practice poses few safety risks but provides little in savings for patients, an AARP report released June 22 concludes

Rx Import Bill Endorsed By Kessler; Beats “Uncontrolled Risk”

Legislation to create a regulated system for importing drugs would be safer than the current system of unregulated personal importation, former FDA Commissioner David Kessler told a Senate Health Committee hearing April 19

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045320

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel